Evonik has completed the construction and commissioning of a new pilot plant for precious metal powder catalysts (PMPC) at its production site in Shanghai.
The set-up is analogous to the existing commercial production plant operating since July 2010 at Evonik’s Xinzhuang site in Shanghai. The purpose of the pilot plant is to accelerate the upscaling process for commercial catalysts and to quickly provide pilot scale PMPC for customer projects. After opening a new R&D and Technical Service lab for catalysts at the Shanghai site in 2014, the pilot plant represents Evonik’s next step in its commitment to the local catalyst market, strengthening its position to meet the growing demand for PMPC in China.
"The pilot plant together with R&D / Technical Service lab represents an important milestone for our operations in China. We now have the complete range for providing catalyst samples and commercial products from lab - pilot-scale - production-scale locally on site,” explains Dr. Harald Seiler, General Manager Business Line Catalysts Greater China.
Precious metal powder catalysts are mostly used in the fast growing Life Sciences & Fine Chemicals market segment in China. They are sold under Evonik’s Noblyst® brand. With the new pilot plant, Evonik offers customers higher flexibility, shorter turnaround time and customized solutions for developing and manufacturing pharmaceuticals, fine chemicals and also industrial chemicals in the Greater China region.
Evonik, the creative industrial group from Germany, is one of the world leaders
in specialty chemicals. Profitable growth and a sustained increase in the value of the company form the heart of Evonik’s corporate strategy. Its activities focus on the key megatrends health, nutrition, resource efficiency and globalization. Evonik benefits specifically from its innovative prowess and integrated technology platforms. Evonik is active in over 100 countries around the world. In fiscal 2014 more than 33,000 employees generated sales of around €12.9 billion and an operating profit (adjusted EBITDA) of about €1.9 billion.
Evonik Industries has been producing specialty chemical products in the Greater China region (Mainland China, Hong Kong and Taiwan) since the late 1970’s; with wide-ranging trading relations already in place prior to this in the region. Evonik regards Greater China as one of the driving forces of the global economy and we consequently endeavour to grow our business in the region. The company now has around 3,000 employees in the Greater China region, the regional sales reached over €1.1 billion in 2014.
In so far as forecasts or expectations are expressed in this press release or where our statements concern the future, these forecasts, expectations or statements may involve known or unknown risks and uncertainties. Actual results or developments may vary, depending on changes in the operating environment. Neither Evonik Industries AG nor its group companies assume an obligation to update the forecasts, expectations or statements contained in this release.